Current regulatory approaches for accessing potential COVID-19 therapies

Current regulatory approaches for accessing potential COVID-19 therapies

Abstract This commentary aims to elaborate challenges in the regulatory approaches for accessing and investigating COVID-19 potential therapies either with off-label use, compassionate use, emergency use or for clinical trials. Since no therapies have been formally approved and completely effective...

Full description

Bibliographic Details
Main Authors: Vesa Halimi, Armond Daci, Simona Stojanovska, Irina Panovska-Stavridis, Milena Stevanovic, Venko Filipce, Aleksandra Grozdanova
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Journal of Pharmaceutical Policy and Practice
Subjects:
COVID-19
Regulatory
EMA
FDA
Clinical studies
Compassionate use
Online Access:http://link.springer.com/article/10.1186/s40545-020-00222-6

Internet

http://link.springer.com/article/10.1186/s40545-020-00222-6

Similar Items